Email updates

Keep up to date with the latest news and content from BMC Genomics and BioMed Central.

Open Access Methodology article

A novel reverse transduction adenoviral array for the functional analysis of shRNA libraries

Angelika Oehmig1, Andrea Klotzbücher2, Maria Thomas1, Frank Weise1, Ursula Hagner1, Ralf Brundiers3, Dirk Waldherr3, Andreas Lingnau2, Achim Knappik3, Michael HG Kubbutat2, Thomas O Joos1 and Hansjürgen Volkmer1*

Author Affiliations

1 NMI Natural and Medical Sciences Institute at the University of Tübingen, Markwiesenstr. 55, 72770 Reutlingen, Germany

2 ProQinase GmbH, Breisacher Str. 117, 79106 Freiburg, Germany

3 MorphoSys AG/AbD Serotec, Lena-Christ-Str. 48, 82152 Martinsried, Germany

For all author emails, please log on.

BMC Genomics 2008, 9:441  doi:10.1186/1471-2164-9-441

Published: 24 September 2008

Abstract

Background

The identification of novel drug targets by assessing gene functions is most conveniently achieved by high-throughput loss-of-function RNA interference screening. There is a growing need to employ primary cells in such screenings, since they reflect the physiological situation more closely than transformed cell lines do. Highly miniaturized and parallelized approaches as exemplified by reverse transfection or transduction arrays meet these requirements, hence we verified the applicability of an adenoviral microarray for the elucidation of gene functions in primary cells.

Results

Here, we present microarrays of infectious adenoviruses encoding short hairpin RNA (shRNA) as a new tool for gene function analysis. As an example to demonstrate its application, we chose shRNAs directed against seven selected human protein kinases, and we have performed quantitative analysis of phenotypical responses in primary human umbilical vein cells (HUVEC). These microarrays enabled us to infect the target cells in a parallelized and miniaturized procedure without significant cross-contamination: Viruses were reversibly immobilized in spots in such a way that the seeded cells were confined to the area of the viral spots, thus simplifying the subsequent addressing of genetically modified cells for analysis. Computer-assisted image analysis of fluorescence images was applied to analyze the cellular response after shRNA expression. Both the expression level of knock-down target proteins as well as the functional output as measured by caspase 3 activity and DNA fractionation (TUNEL) were quantified.

Conclusion

We have developed an adenoviral microarray technique suitable for miniaturized and parallelized analysis of gene function. The practicability of this technique was demonstrated by the analysis of several kinases involved in the activation of programmed cell death, both in tumor cells and in primary cells.